Trial in Progress: Real-World Safety and Effectiveness of Brentuximab Vedotin in Adults with CD30+Lymphoma in China

被引：0
|
作者：
Xu, Pengpeng [1 ]
Cai, Mingci [1 ]
Zhang, Wendy [2 ]
Zhao, Wei Li [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Natl Res Ctr Translat Med Shanghai, State Key Lab Med Genom, Shanghai Inst Hematol,Ruijin Hosp,Sch Med, Shanghai, Peoples R China
[2] Takeda China Int Trading Co Ltd, Shanghai, Peoples R China
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149031
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4552
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-world effectiveness of brentuximab vedotin in the treatment of CD30-positive cutaneous T-cell lymphoma: a single-centre retrospective review
    Berg, M. -H. Henderson
    Davison, K.
    Popradi, G.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (02) : 379 - 381
  • [2] Brentuximab vedotin in treating Chinese patients with lymphoma: A multicenter, real-world study
    Zhang, Xudong
    Qiao, Honghan
    Chai, Xiaofei
    Gao, Xue
    Ma, Rongjun
    Li, Yufu
    Zhu, Zunmin
    Zhang, Mingzhi
    CANCER MEDICINE, 2023, 12 (24): : 21725 - 21734
  • [3] Real-world (RW) treatment patterns with brentuximab vedotin (BV) in patients with Hodgkin lymphoma (HL) or other CD30+malignancies in Switzerland
    Stenner, F.
    Jost, S.
    Novak, U.
    Rossler, W.
    Vogt, D.
    Pavelic, V.
    Hitz, F.
    SWISS MEDICAL WEEKLY, 2023, 153 : 52S - 52S
  • [4] Real-world evidence study of brentuximab vedotin retreatment in patients with cutaneous T-cell lymphoma
    Mitteldorf, C.
    de Masson, A.
    Beylot-Barry, M.
    Wobster, M.
    Zomas, A.
    Stache, V.
    Assaf, C.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S77 - S78
  • [5] Brentuximab vedotin as a bridge to transplant in classical Hodgkin lymphoma: Single tertiary centre real-world experience
    Sarma, A.
    Potter, V.
    Wrench, D.
    Fields, P.
    Yallop, D.
    Devereux, S.
    Patten, P.
    Marcus, R.
    Kassam, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 108 - 109
  • [6] Prospective Assessment of Motor Neurotoxicity and Sarcopenia in CD30+Lymphoma Patients Treated with Brentuximab Vedotin. Single Center Multidisciplinary Unit Experience
    Domenech Eva, Domingo
    Bellver, Marta
    Ferrer, German
    Gonzalez Barca, Eva
    Carro, Itziar
    Oliveira, Ana C.
    Lopez, Patricia
    Sanz-Linares, Gabriela
    Aguilera, Carmen
    Alemany, Montserrat
    Peiro, Inmaculada
    Sureda, Anna
    Velasco, Roser
    BLOOD, 2022, 140 : 9420 - 9421
  • [7] Management of Hodgkin lymphoma in the era of brentuximab vedotin: real-world data from five European countries
    Collins, Graham P.
    Rueda, Antonio
    Salles, Gilles
    von Tresckow, Bastian
    Zaja, Francesco
    LEUKEMIA & LYMPHOMA, 2018, 59 (09) : 2113 - 2120
  • [8] Brentuximab vedotin with chemotherapy for advanced stage untreated classic Hodgkin's lymphoma in a real-world setting.
    Steiner, Raphael
    Cramer, Frederick M.
    Singh, Prachee
    Becnel, Melody
    Alcedo, Pedro E.
    Chin, Collin K.
    Cuglievan, Branko
    Strati, Paolo
    Ahmed, Sairah
    Samaniego, Felipe
    Nair, Ranjit
    Gunther, Jillian Rebecca
    Pinnix, Chelsea Camille
    Fang, Penny
    Dabaja, Bouthaina Shbib
    Feng, Lei
    Lee, Hun Ju
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Brentuximab vedotin in association with bendamustine in refractory or multiple relapsed Hodgkin lymphoma. A retrospective real-world study
    Iannitto, Emilio
    Romano, Alessandra
    Scalzulli, Potito Rosario
    Bonanno, Vincenza
    Scalone, Renato
    Chiarenza, Annalisa
    Pirosa, Maria Cristina
    Caruso, Anastasia Laura
    Minoia, Carla
    Mantuano, Saverio
    De Santis, Gaetano
    Salerno, Marilena
    Crescimanno, Alessandra
    Porretto, Ferdinando
    Li Gioi, Felicina
    Ricciuti, Giuseppina
    Greco, Antonino
    Pavone, Enzo
    Guarini, Attilio
    Tarantini, Giuseppe
    Mannina, Donato
    Consoli, Ugo
    Cascavilla, Nicola
    Di Raimondo, Francesco
    Musso, Maurizio
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (06) : 581 - 587
  • [10] Real-world treatment patterns in patients with Hodgkin lymphoma (HL) treated with brentuximab vedotin (BV) in the US.
    Shao, Changxia
    Cao, Xiting
    Zhou, Wei
    Raut, Monika Kumar
    Liu, Jinan
    Ricart, Alejandro Daniel
    Balakumaran, Arun
    Monberg, Matthew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345